Keratitis Pipeline Review H1 2017 provides Keratitis therapeutics development review, companies involved in Keratitis therapeutics development. The pipeline guide evaluates Keratitis (Ophthalmology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Plus
